While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

When Jenni* started using a medication called liraglutide to lose weight, she noticed changes not just in her appetite, but ...

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...

A US resident lost around 40 kilos using a weight-loss drug but developed vision problems, to be ultimately diagnosed with ...